Zapping cancer spots could delay stronger drugs
NCT ID NCT04299646
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether high-dose, precise radiation (stereotactic radiotherapy) can control a few growing kidney cancer spots while the rest of the disease is stable on current medication. About 77 people with metastatic kidney cancer whose tumors are progressing in only a few places will receive radiation to those spots. The goal is to see if this can delay the need to switch to a new, often stronger, systemic therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stereotactic radiotherapy
- What this could lead to
- If it works, this approach could help people with kidney cancer stay on their current treatment longer and delay switching to harsher drugs.
- What could go wrong
- This is a small, early-phase study with only 77 participants. It may not prove effective, and radiation can cause side effects like fatigue or local tissue damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHD Vendée
NOT_YET_RECRUITINGLa Roche-sur-Yon, France
-
CHR
NOT_YET_RECRUITINGMetz, France
-
CHU Henri Mondor
NOT_YET_RECRUITINGCréteil, France
-
CHU La Timone
NOT_YET_RECRUITINGMarseille, France
-
Centre Antoine Lacassagne
NOT_YET_RECRUITINGNice, France
-
Centre François Baclesse
RECRUITINGCaen, 14076, France
-
Centre Georges François LECLERC
NOT_YET_RECRUITINGDijon, France
-
Centre Haute Energie
NOT_YET_RECRUITINGNice, France
-
Centre Henri Becquerel
NOT_YET_RECRUITINGRouen, France
-
Centre Hospitalier Annecy Genevois
NOT_YET_RECRUITINGPringy, France
-
Centre Jean Perrin
NOT_YET_RECRUITINGClermont-Ferrand, France
-
Centre Léon Bérard
NOT_YET_RECRUITINGLyon, France
-
Centre Oscar Lambret
RECRUITINGLille, France
-
Centre de radiothérapie Guillaume le Conquérant
NOT_YET_RECRUITINGLe Havre, France
-
Centre marie Curie
RECRUITINGValence, France
-
Clinique Claude Bernard
NOT_YET_RECRUITINGAlbi, France
-
Groupement de radiothérapie Oncologie des Pyrénées
NOT_YET_RECRUITINGPau, France
-
ICM
NOT_YET_RECRUITINGMontpellier, France
-
IUCT
NOT_YET_RECRUITINGToulouse, France
-
Institut Bergonié
NOT_YET_RECRUITINGBordeaux, France
-
Institut Curie
NOT_YET_RECRUITINGParis, France
-
Institut Gustave Roussy
RECRUITINGVillejuif, France
-
Institut Paoli Calmette
NOT_YET_RECRUITINGMarseille, France
-
Institut de Cancérologie de Lorraine
NOT_YET_RECRUITINGNancy, France
-
Institut de Cancérologie de l'Ouest
RECRUITINGAngers, France
-
Institut de Cancérologie de l'Ouest
RECRUITINGNantes, France
-
Institut de Cancérologie de la Loire Lucien Neuwirth
NOT_YET_RECRUITINGSaint-Etienne, France
-
Institut de cancérologie de Bourgogne (Dijon, Auxerre, Chalon sur Saône)
RECRUITINGDijon, France
-
Polyclinique de l'Ormeau
RECRUITINGTarbes, France
-
Radiothérapie Bordeaux Nord Aquitaine
NOT_YET_RECRUITINGBordeaux, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple supplement soothe Radiation-Damaged rectums?
- Can imaging reveal how radiation shapes marrow recovery?
- Can a targeted drug combo boost chemoradiation in EGFR-Positive lung cancer?
- Can a pill boost the immune system to fight Hard-to-Treat cancers?
- Can a video call replace a clinic visit for cancer patients on radiotherapy?
- Old drug, new hope: mercaptopurine tested against rare cancer syndrome